Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
Protalix BioTherapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Protalix BioTherapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at Protalix BioTherapeutics received on average a compensation package of $1.5M, a 47% increase compared to previous year.
Average pay of disclosed executives at Protalix BioTherapeutics
Dror Bashan, Chief Executive Officer, received $2.7M in total, which increased by 83% compared to 2022. 40% of Bashan's compensation, or $1.1M, was in stock awards. Bashan also received $892K in bonus, $247K in option awards, $357K in salary, as well as $128K in other compensation.
Eyal Rubin, Chief Financial Officer, received a compensation package of $1M, which decreased by 3% compared to previous year. 29% of the compensation package, or $303K, was in bonus.
Yaron Naos, Senior Vice President, Operations, earned $776K in 2023, a 46% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.